BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
1.080
-0.010 (-0.92%)
At close: Sep 4, 2026, 4:00 PM EDT
1.060
-0.020 (-1.84%)
After-hours: Sep 4, 2026, 7:33 PM EDT
BioCardia Market Cap
BioCardia has a market cap or net worth of $16.35 million as of September 4, 2026. Its market cap has increased by 38.15% in one year.
Market Cap
16.35M
Enterprise Value
12.53M
1-Year Change
38.15%
Ranking
Category
Stock Price
$1.08
ChartMarket Cap Chart
Since October 26, 2016, BioCardia's market cap has decreased from $29.07M to $16.35M, a decrease of -43.76%. That is a compound annual growth rate of -5.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 16.35M | 23.25% |
| Dec 31, 2025 | 13.27M | 32.74% |
| Dec 31, 2024 | 9.99M | -36.30% |
| Dec 29, 2023 | 15.69M | -62.55% |
| Dec 30, 2022 | 41.90M | 28.00% |
| Dec 31, 2021 | 32.73M | -33.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Niki BioSolutions | 18.22M |
| Psyence Biomedical | 17.32M |
| Tempest Therapeutics | 16.46M |
| Citius Pharmaceuticals | 16.13M |
| Vyome Holdings | 15.58M |
| BioVie | 15.09M |
| Passage Bio | 14.96M |
| Lisata Therapeutics | 14.87M |